[Preprint] Randomized Trial: Convalescent Plasma for COVID-19
6 Jul, 2020 | 08:47h | UTCConvalescent Plasma for COVID-19. A randomized clinical trial – medRxiv
Related Commentary on Twitter
Convalescent plasma for Covid-19: trial in Netherlands was stopped because median for neutralizing antibody titers for 79% of patients enrolled was similar to that of the plasma donors. They decided not much chance of benefit; might apply more generally ⬇️ https://t.co/NJogjnFOjK pic.twitter.com/yLNBRYmanl
— Hilda Bastian (@hildabast) July 5, 2020